NCT03943563

Brief Summary

In a preliminary MRI study of healthy volunteers's hands investigators showed that the suppression of the fat signal obtained by the Dixon sequences is greater than that obtained by the "classic" CHESS sequences with a better T1-weighted image quality. The investigators goal now is to compare these sequences in the quantification of the inflammatory activity of rheumatoid arthritis by the RAMRIS score. To investigators knowledge, only one study compared those two types of sequence with many limitations including a limited number of patients included.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 13, 2016

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

March 19, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 9, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2019

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

3.3 years

First QC Date

March 19, 2019

Last Update Submit

April 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ramris score

    * Calculation of the Rheumatoid Arthritis MRI Scoring System (RAMRIS score) for each sequence by two independent radiologists. RAMRIS is used to evaluate erosions (scale, 0-10, 10 representing the worst situation), edema (scale, 0-3, 3 representing the worst situation), and synovitis (scale, 0-3, 3 representing the worst situation) * Blind reading without knowledge of the type of Dixon or "classic" sequence

    an average of 3 year

Study Arms (1)

single cohort

OTHER

There is only one cohort where each patient experiment the "classic sequences" as the standard of care and the DIXON sequences for the study.

Diagnostic Test: Dixon sequences acquisition

Interventions

Dixon sequences acquisition

single cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Rheumatoid arthritis diagnosis for less than 3 years

You may not qualify if:

  • contraindication to Dotarem contrast injection
  • contraindication to MRI due to incompatible implanted material (peacemaker, prosthesis,...)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques Universitaires Saint Luc

Brussels, 1200, Belgium

Location

MeSH Terms

Conditions

Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
None at the time of intervention. At the end of the study, Blind reading without knowledge of the type: Dixon or "classic" sequences.
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2019

First Posted

May 9, 2019

Study Start

May 13, 2016

Primary Completion

August 16, 2019

Study Completion

August 16, 2019

Last Updated

April 10, 2024

Record last verified: 2024-04

Locations